
    
      The purpose of this feasibility study is to evaluate the safety and efficacy of the
      epicardial / endocardial combined procedure for the treatment of drug refractory symptomatic
      Paroxysmal Atrial Fibrillation (AF) patients, using the nContact Numeris速-AF Guided
      Coagulation System with VisiTrax速 epicardially and the Biosense Webster NaviStar速 ThermoCool速
      Diagnostic/Ablation deflectable Tip Catheter in conjunction with the Carto Navigation System
      endocardially.
    
  